نتائج البحث

1

Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5):a placebo-controlled, randomised, phase 3a trial

المؤلفون: Robert Silver, G Bedel, M Yanovskaya, Simon Heller, T Hart, A Golovach, G Cornett, A Luts, A Chang, L Lewy-Alterbaum, H Nguyen, S Hasan, Amir Tirosh, W Biggs, R Pratley, K Blaze, Ole Holm Hels, A Peskov, P Houser, E Klein, Peter Rossing, H Knoble, T Milovanova, P O'Donnell, S Folkerth, H A Frandsen, S Chandran, A Krzeminski, Richard E. Pratley, J Reed, S Sulosaari, Torben Hansen, T Donner, Jan W. Eriksson, R Jackson, N Krasnopeeva, J Pouzar, E Kazakova, J Gumprecht, Thalia Marie Blicher, E Morawski, S Nieminen, Y Shlesinger, J Parker, Klaus Levin, T Maxwell, Z Shaikh, A Nikkola, E Zhdanova, D Nabriski, T Lysenko, P Norwood, G Vagapova, K Khan, J Eriksson, M Hellgren, Ofri Mosenzon, John Strand, M Hewitt, Naim Shehadeh, B Barker, E Haddad, K Eliasson, Y Pergaeva, T Sathyapalan, M Kunitsyna, Thozhukat Sathyapalan, W Gandy, J Soufer, S Chilka, J Lawhead, P Nicol, M Benson, A Odugbesan, S Aronoff, G Gatipon, R Abramof, L Gonzalez-Orozco, C Desouza, O Mosenzon, I Beshay, H Traylor, B Snyder, Robert S. Lindsay, A Cleland, K Metsärinne, Paweł Bogdański, K Forshaw, M Sergeeva-Kondrachenko, Cyrus Desouza, M Hitz, S Plevin, K Astamirova, N Uhlenius, R Huntley, D Alpenidze, B Delgado, L Zarutskaya, Signe Rosenlund, John A. McKnight, P Levin, E Frolova, S Heller, P E Jakobsen, A Kapoor, R Busch, S Chaidarun, L Connery, S Hietaniemi, Sten Madsbad, M. Shamkhalova, S Lindmark, B Hella, L Belousova, C Mbogua, L Kargina

المصدر: Mosenzon, O, Blicher, T M, Rosenlund, S, Eriksson, J W, Heller, S, Hels, O H, Pratley, R, Sathyapalan, T, Desouza, C, PIONEER 5 Investigators, Abramof, R, Alpenidze, D, Aronoff, S, Astamirova, K, Barker, B, Bedel, G, Belousova, L, Benson, M, Beshay, I, Biggs, W, Blaze, K, Bogdanski, P, Busch, R, Chaidarun, S, Chandran, S, Chang, A, Chilka, S, Cleland, A, Connery, L, Cornett, G, Delgado, B, Desouza, C, Donner, T, Eliasson, K, Eriksson, J, Folkerth, S, Forshaw, K, Frandsen, H A, Frolova, E, Gandy, W, Gatipon, G, Golovach, A, Hansen, T K, Hitz, M, Jakobsen, P E, Levin, K, Madsbad, S, Nguyen, H, Parker, J, Reed, J, Rossing, P, Yanovskaya, M, Zarutskaya, L & Zhdanova, E 2019, ' Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5) : a placebo-controlled, randomised, phase 3a trial ', The Lancet Diabetes and Endocrinology, vol. 7, no. 7, pp. 515-527 . https://doi.org/10.1016/S2213-8587Test(19)30192-5
Mosenzon, O, Blicher, T M, Rosenlund, S, Eriksson, J W, Heller, S, Hels, O H, Pratley, R, Sathyapalan, T, Desouza, C & PIONEER 5 Investigators 2019, ' Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5) : a placebo-controlled, randomised, phase 3a trial ', The Lancet Diabetes & Endocrinology, vol. 7, no. 7, pp. 515-527 . https://doi.org/10.1016/S2213-8587Test(19)30192-5

مصطلحات موضوعية: Male, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Population, Glucagon-Like Peptides, Administration, Oral, 030209 endocrinology & metabolism, Type 2 diabetes, Placebo, Glucagon-Like Peptide-1 Receptor, law.invention, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Double-Blind Method, Randomized controlled trial, law, Internal medicine, Internal Medicine, medicine, Clinical endpoint, Humans, Diabetic Nephropathies, Renal Insufficiency, 030212 general & internal medicine, education, Aged, education.field_of_study, business.industry, Semaglutide, Middle Aged, medicine.disease, Discontinuation, Clinical trial, Treatment Outcome, Diabetes Mellitus, Type 2, Female, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d569511b15de88f728dd8364203edd9Test
https://curis.ku.dk/ws/files/251035512/Efficacy_and_safety_of_oral_semaglutide_in_patients_with_type_2_diabetes_and_moderate_renal_impairment_PIONEER_5_accepted_version_.pdfTest

2

Adherence to Cardiovascular Disease Medications: Does Patient-Provider Race/Ethnicity and Language Concordance Matter?

المؤلفون: Carol M. Mangione, Ana H. Traylor, Usha Subramanian, Connie S. Uratsu, Julie A. Schmittdiel

المصدر: Journal of General Internal Medicine
Traylor, AH; Schmittdiel, JA; Uratsu, CS; Mangione, CM; & Subramanian, U. (2010). Adherence to cardiovascular disease medications: Does patient-provider race/ethnicity and language concordance matter?. Journal of General Internal Medicine, 25(11), 1172-1177. doi: 10.1007/s11606-010-1424-8. UCLA: Retrieved from: http://www.escholarship.org/uc/item/1m86r6msTest
Traylor, Ana H.; Schmittdiel, Julie A.; Uratsu, Connie S.; Mangione, Carol M.; & Subramanian, Usha. (2010). Adherence to Cardiovascular Disease Medications: Does Patient-Provider Race/Ethnicity and Language Concordance Matter?. Journal of General Internal Medicine, 25(11), pp 1172-1177. doi: 10.1007/s11606-010-1424-8. Retrieved from: http://www.escholarship.org/uc/item/1c72b0vhTest

مصطلحات موضوعية: Gerontology, Adult, medicine.medical_specialty, Concordance, education, Foreign language, Ethnic group, MEDLINE, Disease, Ethnic origin, 030204 cardiovascular system & hematology, Medication Adherence, 03 medical and health sciences, 0302 clinical medicine, medical workforce diversity, Risk Factors, Diabetes mellitus, Medicine & Public Health, Internal Medicine, medicine, Ethnicity, Humans, Hypoglycemic Agents, 030212 general & internal medicine, Antihypertensive Agents, Original Research, Hypolipidemic Agents, Language, racial/ethnic and linguistic health disparities, Physician-Patient Relations, diabetes, business.industry, Public health, racial/ethnic minority health, Racial Groups, medicine.disease, cardiovascular risk factor control, race/ethnic and language concordance, United States, 3. Good health, Cardiovascular Diseases, medication adherence, Patient Compliance, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7aca596b3d609dfb2032fd648e401b0Test
http://europepmc.org/articles/PMC2947630Test

3

The Predictors of Patient-Physician Race and Ethnic Concordance: A Medical Facility Fixed-Effects Approach

المؤلفون: Usha Subramanian, Julie A. Schmittdiel, Connie S. Uratsu, Carol M. Mangione, Ana H. Traylor

المصدر: Health Services Research. 45:792-805

مصطلحات موضوعية: Chronic care, medicine.medical_specialty, Affirmative action, education.field_of_study, business.industry, Health Policy, Concordance, Population, Ethnic group, Race and health, Family medicine, Health care, medicine, business, education, Socioeconomic status

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::6e1f9e4a996bb119cdfaf3a023d0c09dTest
https://doi.org/10.1111/j.1475-6773.2010.01086.xTest

4

Lack of Detectable Radiation Hypersensitivity in Lymphoblastoid Cells from Multiple Pedigrees of Familial Alzheimer Disease

المؤلفون: Thomas D. Bird, Thomas H. Lampe, Eileen Bryant, Gilford H. Traylor, George M. Martin, Charles E. Ogburn

المصدر: Alzheimer Disease & Associated Disorders. 7:88-97

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b726b4357669205d2807ab591c23b032Test
https://doi.org/10.1097/00002093-199307020-00004Test

5

The association of patient-physician gender concordance with cardiovascular disease risk factor control and treatment in diabetes

المؤلفون: Ana H. Traylor, Julie A. Schmittdiel, Usha Subramanian, Assiamira Ferrara, Carol M. Mangione, Connie S. Uratsu

المصدر: Journal of women's health (2002), vol 18, iss 12
Schmittdiel, JA; Traylor, A; Uratsu, CS; Mangione, CM; Ferrara, A; & Subramanian, U. (2009). The Association of Patient-Physician Gender Concordance with Cardiovascular Disease Risk Factor Control and Treatment in Diabetes. JOURNAL OF WOMENS HEALTH, 18(12), 2065-2070. doi: 10.1089/jwh.2009.1406. UCLA: Retrieved from: http://www.escholarship.org/uc/item/0m93111nTest

مصطلحات موضوعية: Male, Quality Assurance, Health Care, Cross-sectional study, Disease, Practice Patterns, Comorbidity, Cardiovascular, Medical and Health Sciences, California, 7.1 Individual care needs, Practice Patterns, Physicians', Hypolipidemic Agents, Diabetes, Managed Care Programs, General Medicine, Middle Aged, Causality, Heart Disease, Treatment Outcome, Cardiovascular Diseases, Hypertension, Female, Public Health, Type 2, Adult, medicine.medical_specialty, Concordance, Hyperlipidemias, Trust, Physicians, Women, Sex Factors, Clinical Research, Diabetes mellitus, Internal medicine, Physicians, medicine, Diabetes Mellitus, Humans, Women, Risk factor, Antihypertensive Agents, Aged, Physician-Patient Relations, Physicians', business.industry, Prevention, Primary care physician, Original Articles, medicine.disease, Health Care, Blood pressure, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Physical therapy, Patient Compliance, Management of diseases and conditions, business, Quality Assurance

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bd8b60a3167431e6b9d5299d6fff458Test
https://pubmed.ncbi.nlm.nih.gov/20044871Test

6

The association of patient age with cardiovascular disease risk factor treatment and control in diabetes

المؤلفون: Ana H. Traylor, Connie S. Uratsu, Julie A. Schmittdiel, Joeseph V. Selby, Usha Subramanian, Carol M. Mangione, Neha Gavin

المصدر: Journal of general internal medicine, vol 24, iss 9
Subramanian, U; Schmittdiel, JA; Gavin, N; Traylor, A; Uratsu, CS; Selby, JV; et al.(2009). The association of patient age with cardiovascular disease risk factor treatment and control in diabetes. Journal of General Internal Medicine, 24(9), 1049-1052. doi: 10.1007/s11606-009-1059-9. UCLA: Retrieved from: http://www.escholarship.org/uc/item/54z5z0f4Test

مصطلحات موضوعية: Male, Aging, Glycated Hemoglobin A, Treatment intensification, Cardiovascular, treatment intensification, Risk Factors, cardiovascular disease, Hyperlipidemia, Epidemiology, 80 and over, hyperlipidemia, adherence, Young adult, older adults, Aged, 80 and over, Brief Report, Diabetes, Age Factors, Hemoglobin A, Middle Aged, Treatment Outcome, Cardiovascular Diseases, Female, Adult, medicine.medical_specialty, hypertension, Adolescent, Systole, Clinical Sciences, Glycosylated, and over, Young Adult, Patient age, Disease risk factor, Clinical Research, Internal medicine, Diabetes mellitus, General & Internal Medicine, Internal Medicine, medicine, Diabetes Mellitus, Humans, Risk factor, Aged, Glycated Hemoglobin, business.industry, medicine.disease, Surgery, Patient Care, business